Univest
Univest
  • Markets

Sigachi Industries (SIGACHI) Share Price Falls 12.13% Today; What the Decline Shows

  • September 15, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Sigachi Industries Share Price
Sigachi Industries (SIGACHI)share price fell to Rs 33.31 today, down 12.13% from the previous close. Market cap was Rs 1,448.61 crore.

Sigachi Industries Share Price fell to Rs 33.31 on 15 September 2026, down 12.13% for the day. The small-cap pharma stock’s market capitalisation stood at Rs 1,448.61 crore. Intraday data shows the stock opened at Rs 37.85, touched the same level as the day’s high, and later fell to Rs 32.85, underlining a clear loss of strength through the session.

For investors following the stock, the supplied dataset confirms the magnitude of the move but does not identify any company-specific trigger. What it does provide is a useful snapshot of price action, turnover, valuation, profitability and industry context. That allows today’s decline to be read not just as a one-session event, but as a market move that can be compared with the company’s broader financial profile.

That context matters because Sigachi Industries operates in Healthcare, within the Pharmaceuticals & Drugs industry. The same dataset includes industry benchmark medians, averages and selected peers, making it possible to assess whether the stock looks expensive or inexpensive relative to that universe, and whether return ratios support the valuation being assigned.

Table of Contents

Toggle
  • Sigachi Industries (SIGACHI) Share Price Today: Price Action Analysis
  • Sigachi Industries (SIGACHI) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching the Stock
  • About Sigachi Industries
  • Track Sigachi Industries Share Price on Univest
  • Frequently Asked Questions
    • Why is Sigachi Industries Share Price falling today?
    • What is Sigachi Industries Share Price today?
    • What is the company’s market capitalisation?
    • How does its P/E compare with the industry?
    • How does its P/B compare with the industry?
    • Are profitability ratios above industry levels?
    • How does the stock compare with major pharma peers?

Sigachi Industries (SIGACHI) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 33.31
Previous Close Rs 37.91
Today's Move -Rs 4.60 (-12.13%)
Open Rs 37.85
High Rs 37.85
Low Rs 32.85
Turnover Rs 1.21 crore
Market Capitalisation Rs 1,448.61 crore
Market Cap Category Small Cap

Sigachi Industries Share Price Today reflects a sharp reset from the previous close. The stock started at Rs 37.85, almost unchanged from Rs 37.91, but that opening level also remained the session high. From there, the price weakened to Rs 32.85 before trading at Rs 33.31, leaving an absolute day change of Rs 4.60 lower.

This pattern is notable because there was no intraday recovery back above the opening zone. In practical terms, the market did not sustain buying interest after the start of trade. Turnover of Rs 1.21 crore also shows the move was not entirely unnoticed, even if the data alone does not indicate why market participants sold the stock.

Technical reference points add another layer. The RSI is 77.2, while the 50-day moving average is Rs 31.11 and the 200-day moving average is Rs 24.66. Even after today’s decline, the stock remains above both moving averages. That means the session was weak, but the supplied medium- and longer-term reference levels still sit below the current price.

Sigachi Industries (SIGACHI) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,448.61 crore
P/E Ratio 57.14x
P/B Ratio 2.73x
ROE 14.49%
ROCE 16.42%
EPS Rs 0.66
Book Value Per Share Rs 13.87
Dividend Yield 0%

Sigachi Industries Share Price is now being judged against a set of fundamentals that show mixed signals. The company has positive profitability ratios, but it also trades at a relatively elevated earnings multiple.

The stock’s P/E ratio is 57.14, while its P/B ratio is 2.73. ROE stands at 14.49% and ROCE at 16.42%, both comfortably in double digits. EPS is Rs 0.66 and book value per share is Rs 13.87. Dividend yield is 0, meaning the current dataset does not indicate a cash yield at the present price.

Taken together, these numbers suggest the market is not valuing the company as a low-multiple business. At the same time, its profitability metrics are not weak. That combination often leaves investors balancing two questions: whether operational returns justify the valuation, and whether a sharp one-day decline changes that valuation discussion in a meaningful way.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 57.14x
Benchmark Median P/E 32.72x
Benchmark Average P/E 49.15x
Benchmark P/E Range 3.34x to 693.7x
Company P/B Ratio 2.73x
Benchmark Median P/B 3.05x
Benchmark Average P/B 4.37x
Company ROE 14.49%
Benchmark Median ROE 11.69%
Benchmark Average ROE 10.54%
Company ROCE 16.42%
Benchmark Median ROCE 13.24%
Benchmark Average ROCE 13.09%
Company Market Capitalisation Rs 1,448.61 crore
Benchmark Median Market Cap Rs 704.59 crore
Benchmark Average Market Cap Rs 13,873.11 crore

The industry benchmark covers 204 companies in Pharmaceuticals & Drugs. Within that set, the company’s P/E of 57.14 is above the median of 32.72 and the average of 49.15. So on earnings, the stock sits above central industry valuation levels.

Price to book looks different. The company’s P/B of 2.73 is below the benchmark median of 3.05 and average of 4.37. Profitability also compares favourably: ROE of 14.49% is above the median of 11.69% and average of 10.54%, while ROCE of 16.42% is above the median of 13.24% and average of 13.09%.

On size, market capitalisation of Rs 1,448.61 crore is above the industry median of Rs 704.59 crore but far below the average of Rs 13,873.11 crore, which is influenced by much larger pharma names. Overall, the benchmark data suggests a company with better-than-median returns, a lower-than-median book multiple, and a higher-than-median earnings multiple.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,41,957.5 36.54 5.11 14.85 19.11
Divi's Laboratories DIVISLAB 2,47,576 84.64 14.02 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,89,233.01 86.76 21.08 26.76 19.27
Zydus Lifesciences ZYDUSLIFE 1,11,670.55 24.74 4.14 19.69 21.39
Cipla CIPLA 1,10,272.68 32.72 3.14 11.83 16

Against supplied peers, Sigachi Industries is far smaller in market value than Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. That does not by itself determine value, but it is important when comparing scale and market positioning.

On valuation, its P/E of 57.14 is above Sun Pharma’s 36.54, Zydus Lifesciences’ 24.74 and Cipla’s 32.72, but below Divi’s Laboratories’ 84.64 and Torrent Pharmaceuticals’ 86.76. Its P/B of 2.73 is lower than all five of these peers. On returns, ROE of 14.49% is near Sun Pharma’s 14.85% and above Cipla’s 11.83%, but below Divi’s, Torrent and Zydus. ROCE of 16.42% is slightly above Cipla’s 16 and below the other four peers listed.

That leaves a mixed picture. The company is not among the larger pharma names, its earnings multiple still looks relatively rich versus some established peers, and its return profile is respectable without clearly leading this comparison set.

Why Investors Are Watching the Stock

  • The stock fell 12.13% to Rs 33.31 after opening at Rs 37.85.
  • The day’s high was also Rs 37.85, while the low was Rs 32.85.
  • Turnover stood at Rs 1.21 crore.
  • P/E of 57.14 is above the industry median of 32.72.
  • ROE of 14.49% and ROCE of 16.42% are above industry medians.
  • The current price remains above the 50 DMA of Rs 31.11 and 200 DMA of Rs 24.66.

About Sigachi Industries

Sigachi Industries operates in the Healthcare sector within the Pharmaceuticals & Drugs industry. Based on the supplied classification, it is part of the same-industry benchmark set used for valuation and profitability comparison. With a market capitalisation of Rs 1,448.61 crore, the company falls in the small-cap category.

Track Sigachi Industries Share Price on Univest

UseSigachi Industries (SIGACHI) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

On Univest, users can monitor Sigachi Industries Share Price alongside market-cap data, valuation ratios, profitability metrics, peer comparison and sector benchmarks. Those figures help place sharp daily moves in a broader analytical context.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why is Sigachi Industries Share Price falling today?

Ans. The stock is down 12.13% at Rs 33.31 compared with the previous close of Rs 37.91. The supplied data confirms the decline but does not provide a company-specific reason for it.

What is Sigachi Industries Share Price today?

Ans. Sigachi Industries Share Price Today is Rs 33.31. The stock opened at Rs 37.85, touched a high of Rs 37.85 and a low of Rs 32.85. The previous close was Rs 37.91.

What is the company’s market capitalisation?

Ans. The market capitalisation is Rs 1,448.61 crore, placing the company in the Small Cap category. The company operates in the Healthcare sector. Its P/E ratio is 57.14x. ROE is 14.49% and ROCE is 16.42%.

How does its P/E compare with the industry?

Ans. Its P/E is 57.14, above the same-industry median of 32.72 and average of 49.15. Its P/B ratio is 2.73x. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.

How does its P/B compare with the industry?

Ans. Its P/B is 2.73, below the industry median of 3.05 and average of 4.37. The company trades at a P/E ratio of 57.14x. The relevant peer median P/E is 32.72x.

Are profitability ratios above industry levels?

Ans. Yes. ROE is 14.49% versus an industry median of 11.69%, and ROCE is 16.42% versus a median of 13.24%. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.

How does the stock compare with major pharma peers?

Ans. It is much smaller by market cap than the listed peers in the comparison table. Its P/E is above Sun Pharma, Zydus Lifesciences and Cipla, but below Divi's Laboratories and Torrent Pharmaceuticals.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply